Articles tagged with: CATIE

HIV Stigma 101

published: June, 27, 2017 Written by // Bob Leahy - Publisher Categories // Research, Health, Living with HIV, Bob Leahy - Publisher

A new Canadian video featuring two well known poz advocates explores what HIV Stigma looks like. Produced by Universities Without Walls, the Ontario HIV Network (OHTN)

HIV Stigma 101

It’s hurtful to those of us living with HIV, it’s unfair and it contributes to the spread of HIV. These are three good reasons why we need to understand HIV stigma’s role, how we stop or at least reduce it and track our progress in doing so.  In the video below, Muluba Habanyama and Francisco Ibanez-Carrasco, both working on a current HIV stigma study, explain the basics. It’s a good primer; we all talk about stigma (a LOT) but don’t always stop to pare it down, to think about its

Criminalization of HIV non-disclosure: is the tide turning?

published: June, 19, 2017 Written by // Rob Olver - Editor Categories // Activism, Social Media, Conferences, Current Affairs, Features and Interviews, International , Legal, Media, Rob Olver - Editor

Rob Olver interviews Edwin J. Bernard, Global Co-ordinator of the HIV Justice Network at "Rethinking Justice 2017 Symposium on HIV, Law and Human Rights

Criminalization of HIV non-disclosure: is the tide turning?

One of the things that made the “Rethinking Justice: 2017 Symposium on HIV, Law and Human Rights” a “must-attend” for me was the presence of Edwin J. Bernard, Global Co-ordinator of the HIV Justice Network and foremost expert on HIV criminalization worldwide. PositiveLite.com had interviewed Edwin before and published him as well, but that was all the way back in 2012 and 2016 so I attended the symposium hoping for the chance of an interview. I wasn’t disappointed. Edwin proved very

U=U and the overly-broad criminalization of HIV nondisclosure

published: June, 13, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // African, Caribbean and Black, Social Media, Activism, As Prevention , Gay Men, Youth, Current Affairs, Treatment Guidelines -including when to start, Women, CATIE - HIV and Hep C Info Resource, Health, Legal, Treatment, Media, Opinion Pieces

From CATIE Blog, Nicholas Caivano and Sandra Ka Hon Chu give their take on the legal ramifications of Undetectable = Untransmittable (U = U).

U=U and the overly-broad criminalization of HIV nondisclosure

People living with HIV in Canada have been charged with some of the most serious offences in the Criminal Code, even in cases of consensual sex where there was negligible or no risk of HIV transmission, no actual transmission and no intent to transmit. The Undetectable=Untransmittable (“U=U”) campaign is based on scientific research, including the ground-breaking PARTNER study, establishing that when a person living with HIV on treatment maintains an undetectable viral load for at least

‘A near normal lifespan for people with HIV?’ For whom is this true - and who misses out?

published: May, 15, 2017 Written by // Megan DePutter Categories // Social Media, Aging, As Prevention , General Health, Treatment Guidelines -including when to start, Health, International , Smoking Cessation , Treatment, Megan DePutter, Opinion Pieces

Megan DePutter: "We can’t ignore these vulnerabilities that can put individuals more at risk both for acquiring HIV, getting diagnosed late, or struggling to adhere to the medication."

‘A near normal lifespan for people with HIV?’ For whom is this true - and who misses out?

Yesterday, the Lancet published a study titled ‘Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies’. This study found that ‘even in the late ART era, survival during the first three years of ART continues to improve.’ In fact, the authors found that ‘between 1996 and 2010, life expectancy in 20-year-old patients starting ART increased by about nine years in women and ten years in men.’ The authors con

Webinar: preventing suicide among gay and bisexual men, Tuesday May 30th 10:00am PST

published: May, 15, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, Gay Men, CATIE, Mental Health, Upcoming Events, Health, CATIE - HIV and Hep C Info Resource, Living with HIV, Media

Presented by CATIE and The Network: BC's gbMSM Health Resource.

Webinar: preventing suicide among gay and bisexual men, Tuesday May 30th 10:00am PST

Partners and Collaborators: Register Here! Suicide is the ninth leading cause of death among Canadians, responsible for nearly 4000 deaths each year. While everyone is susceptible to the feelings of hopelessness and despair that precede suicide, gay and bisexual men are 4 times more likely to attempt suicide in their lifetime than heterosexual men. Moreover, the suicide rate among gay and bisexual men in Canada is comparable to the current death toll from HIV/AIDS.  Suicide is preventable.

Research finds that harm reduction and ART helped to reduce the spread of HIV in Vancouver

published: May, 02, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , CATIE, Treatment Guidelines -including when to start, Research, CATIE - HIV and Hep C Info Resource, Health, Treatment

Sean R. Hosein of CATIE reports on research in Vancouver that attempted to study the relative impact that ART, harm reduction or both can have on the spread of HIV.

Research finds that harm reduction and ART helped to reduce the spread of HIV in Vancouver

In clinical trials, the early initiation of HIV treatment (ART) stabilizes the immune system and significantly reduces the risk of developing AIDS-related infections and cancers. This benefit of ART is so profound that researchers increasingly expect that many ART users will live into their senior years. Key to reaping the benefit of ART is achieving an undetectable level of HIV in the blood (viral load) and maintaining it through daily use of ART and regular checkups and laboratory monitori

CATIE joins in mourning the death of a brilliant scientist and friend – Professor Dr. Mark Wainberg

published: April, 14, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Activism, Social Media, As Prevention , CATIE, Current Affairs, General Health, Treatment Guidelines -including when to start, CATIE - HIV and Hep C Info Resource, Health, Treatment, Media

Those of us in Canada and around the globe who struggle to end the HIV epidemic have lost a friend, mentor and key ally.

CATIE joins in mourning the death of a brilliant scientist and friend – Professor Dr. Mark Wainberg

Dr. Mark Wainberg passed away suddenly earlier this week. He was a brilliant scientist who helped to greatly extend our understanding about HIV and how this virus can develop resistance to treatment.  Dr. Wainberg’s career was centred at McGill University where he was the Director of the McGill AIDS Centre.  He became internationally renowned for the impact that his laboratory had on HIV treatment, as well as for the global impact of his efforts to help make HIV treatment more accessible.

Attending CAHR2017 as a CATIE rapporteur

published: April, 13, 2017 Written by // Rob Olver - Editor Categories // African, Caribbean and Black, Social Media, Activism, Aging, As Prevention , Gay Men, Conferences, Youth, Treatment Guidelines -including when to start, Mental Health, Research, Women, Health, Legal, Treatment, Living with HIV, Opinion Pieces, Rob Olver - Editor

Rob Olver reports back on #CAHR2017

Attending CAHR2017 as a CATIE rapporteur

As I prepared to attend CAHR2017 in Montreal I was elated, but a bit nervous as well. I hadn’t qualified for a community scholarship but had been accepted as a CATIE rapporteur. This meant I’d be covering the event for CATIE as well as for PositiveLite.com and then on the final day, my fellow rapporteurs and I would present a report back to the rest of the conference with a distillation of what we’d seen and heard. So yes, I had butterflies, mostly because I haven’t done much science w

The capsid inhibitor—a new class to enter clinical trials

published: April, 13, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // African, Caribbean and Black, Social Media, As Prevention , Gay Men, CATIE, Youth, General Health, Treatment Guidelines -including when to start, Women, CATIE - HIV and Hep C Info Resource, Sexual Health, Health, International , Treatment, Media

From CATIE: "This finding suggests that the capsid inhibitor has potential for intermittent dosing in people—perhaps every one or two months."

The capsid inhibitor—a new class to enter clinical trials

Most approved anti-HIV drugs work by interfering with an enzyme and/or protein that is needed by HIV-infected cells to make new viruses. A journey through the cell The capsid is the name given to the proteins that surround HIV’s genetic material. Upon HIV attaching itself to a target cell of the immune system, the virus sends its genetic material (RNA) into the cell. As the genetic material is surrounded by the capsid, it is protected from detection by the cell’s internal sensors. The ca

From the Conference on Retroviruses and Opportunistic Infections (CROI) 2017; new drugs, new hope and possible timelines

published: April, 07, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , CATIE, Gay Men, Treatment Guidelines -including when to start, Research, CATIE - HIV and Hep C Info Resource, Treatment, Media

From CATIE, Sean R. Hosein reports on several new drugs that are in varying stages of development.

From the Conference on Retroviruses and Opportunistic Infections (CROI) 2017;  new drugs, new hope and possible timelines

Une version française est disponible ici. At the recent Conference on Retroviruses and Opportunistic Infections (CROI), which took place in Seattle from February 13 to 16, 2017, researchers presented data about new anti-HIV compounds in development, including the following: a new integrase inhibitor – bictegravir a new nuke (NRTI) – code-named GS-9131 a non-nuke (NNRTI) – doravirine a new protease inhibitor – code-named GS-PI1 a capsid inhibitor (a new cla

<<  1 2 [34 5 6 7  >>